Drug Shortage Report for ATROPINE SULFATE INJECTION

Last updated on 2020-07-17 History
Report ID 111888
Drug Identification Number 02426269
Brand name ATROPINE SULFATE INJECTION
Common or Proper name ATROPINE SULFATE INJECTION
Company Name LABORATOIRE AGUETTANT
Market Status MARKETED
Active Ingredient(s) ATROPINE SULFATE
Strength(s) 0.5MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 10 syringes per box
ATC code A03BA
ATC description BELLADONNAAND DERIVATIVES, PLAIN
Reason for shortage Demand increase for the drug.
Anticipated start date 2020-07-16
Actual start date
Estimated end date
Actual end date 2020-07-16
Shortage status Resolved
Updated date 2020-07-17
Company comments COVID 19 has caused unprecedented drug demand and a potential risk of drug shortage.
Health Canada comments
Tier 3 Status No
Contact Address 1, RUE ALEXANDER FLEMING
LYON, RHÔNE
FRANCE 69007
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2020-07-17 French Compare
v12 2020-07-17 English Compare
v11 2020-07-16 English Compare
v10 2020-07-09 French Compare
v9 2020-07-09 English Compare
v8 2020-07-06 French Compare
v7 2020-07-06 English Compare
v6 2020-06-26 French Compare
v5 2020-06-26 English Compare
v4 2020-04-27 French Compare
v3 2020-04-27 English Compare
v2 2020-04-12 French Compare
v1 2020-04-12 English Compare

Showing 1 to 13 of 13